The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on confidential data.
This rejection became public after a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson later clarified that the United States was demanding access to genetic material for scientific study and profit but refused to share the benefits from any future vaccines.
"We must now begin the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged continued negotiations to secure a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.
Broader Background
This development follows a similar situation in Kenya, where a high court halted a related deal with the US after legal challenges were raised about the security of citizens' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
According to reports, 16 nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the basic resources for medical research without any assurance that the resulting innovations would be accessible to our population if a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems previously set up via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This framework is intended to ensure that when a country provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how subsequent collaboration might be structured in a way that respects the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations should continue given that a large portion of the nation's HIV programmes relied on external financing.
"Where technical issues arise, including those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
The situation emphasises the continuing debate between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.